A Randomized Trial Assessing Once Daily Administration of Mometasone Furoate DPI in Asthmatics (Study P02177)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2002
This will be an open-label, randomized, parallel-group comparison of mometasone furoate dry powder inhaler (MF-DPI) 400 mcg once daily administered in the morning vs. the evening for 12 weeks in subjects with asthma.
Epistemonikos ID: 60b60e008681465a15fdd13dcf3f3674f4660f89
First added on: May 05, 2024